NCT06699680View on ClinicalTrials.gov

Phase 1 Study of PRX019 in Healthy Adult Volunteers

PHASE1RecruitingINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

November 8, 2024

Primary Completion Date

January 23, 2026

Study Completion Date

January 23, 2026

Conditions

Healthy Participants Study

Interventions

DRUG

PRX019

Specified dose on specified days

DRUG

Placebo

Placebo

Trial Locations (1)

90720

RECRUITING

Local Institution, Los Alamitos

All Listed Sponsors

lead

Prothena Biosciences Ltd.

INDUSTRY